Quest Diagnostics Incorporated Stock Performance

Relative Risk vs. Return Landscape

If you had invested $ 20,535 in Quest Diagnostics Incorporated on February 10, 2026 and sold it today, you would have lost $ 1,554 , a decline of 7.57% over 90 days. Quest Diagnostics Incorporated is generating negative expected returns assuming volatility of 1.33% on return distribution over 90 days investment horizon. In relative terms, Quest Diagnostics exhibits above-average volatility, exceeding roughly 89% of comparable stocks, and DGX delivers lower expected returns than 99% of comparable equities over the next 90 days.This comparison focuses on expected return, realized volatility, and risk efficiency versus the market. It is informative when expected return is read together with volatility rather than in isolation. Over a 90-day investment horizon, DGX has been underperforming the market. Compounding this underperformance, DGX is 1.43 times more volatile than its market benchmark. It converts risk into return at a rate of about -0.09%. Dow Jones Industrial is currently generating roughly -0.01% per unit of volatility.

Target Price Odds to finish over Current Price

Over a 90-day investment horizon, Quest Diagnostics has a beta of 0.31 suggesting as returns on the market go up, Quest Diagnostics's average returns tend to increase less than the benchmark. However, during a bear market, the loss from holding Quest Diagnostics Incorporated tends to be smaller as well. Additionally, Quest Diagnostics Incorporated has a negative alpha, implying that risk has not been adequately compensated by returns. DGX is significantly underperforming the Dow Jones Industrial.

Predictive Modules for Quest Diagnostics

Forecasting Quest Diagnostics requires combining quantitative signals with evolving sentiment and fundamental trends. Each approach has strengths and limitations, making diversified forecasting strategies especially important for Quest Diagnostics.

Sentiment Range Low Sentiment High 188.57 189.90 191.23 Details

Intrinsic Valuation Low Intrinsic High 170.83 210.55 211.88 Details

Naive Forecast Low Next High 184.77 186.09 187.42 Details

Analyst Consensus Low Target High 203.16 223.25 247.81 Details

Quest Diagnostics is positioned within its peer group by benchmarking margins, returns, and multiples. This peer-relative view identifies where Quest Diagnostics leads, trails, or tracks its competitive set.

Primary Risk Indicators

Over the past two decades, the stock market has experienced significant volatility affecting Quest Diagnostics. Quest Diagnostics has seen dramatic price moves that have reshaped risk profiles for its holders.

Investor Alerts and Insights

Targeted alerts for Quest Diagnostics provide the responsiveness needed to evaluate market conditions and assess potential outcomes. These notifications for Quest Diagnostics help investors make timely decisions in response to significant stock events.

Price Density Drivers

Quest Diagnostics Fundamentals Growth